In this second biennial conference, and first in-person clinico-radiologic symposium on tumors of the alimentary tract from esophagus to anus, we are excited to host faculty who are world-renowned experts in the management of these tumors. Alimentary oncology exemplifies a dynamic, rapidly shifting landscape of evolving treatment paradigms and diagnostic challenges providing a wealth of opportunity in the realm of imaging, liquid biopsy, artificial intelligence and genetic-alteration-targeted treatment. Immunotherapy has become a potential game-changer for sub-populations of patients with esophageal and rectal cancer, placing new demands on the multidisciplinary team and turbo-charging new clinical trials. We will push the envelope with lectures on radiologists as active clinical trialists and update our knowledge with discussions of new molecular imaging and theranostic agents. With lecturers who are instrumental in prior and ongoing pivotal multi-center national clinical trials and a
Contact: Jessica Bauer
Accreditation Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. AMA Credit Designation Statement Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. ABS CC Recognition Statement Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.